Celltrion partners with US pharmacy chain for Yuflyma sales
Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.
CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.
Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.
Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.
Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.
Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.
“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.
Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.
PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.
Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.
(责任编辑:건강)
下一篇:HiteJinro to produce soju in Vietnam
- ·Sabre fencer, swimming relay team eye historic medals
- ·BTS' Suga begins military service
- ·Russian top diplomat to visit NK, accuses US of fueling tensions on Korean Peninsula
- ·Dodgers prospect trying to fit in with S. Korean nat'l baseball team
- ·[Herald Interview] ‘Another Body,’ a riveting documentary on devasting effects of deepfake porn
- ·Welcome Daehakro Festival lights up Seoul's stage hub
- ·[Weekender] Behind the scenes of Korean food crazes
- ·BTS' Suga begins military service
- ·Ministry uncovers 1,802 Youth Protection Act violations
- ·Another suspect of Tajik duo behind S. Korean money exchange robbery nabbed
- ·Gangwon Forestry Exhibition 2023 kicks off in Korea's 'forest capital'
- ·Dodgers prospect trying to fit in with S. Korean nat'l baseball team
- ·[Photo News] Mudeungsan fully opens door to public after 57 years
- ·MBK chairman makes donation to promote Korean art at New York's Met
- ·[Today’s K
- ·Number of deaths in cycling accidents soars
- ·Xi says he will consider S. Korea visit
- ·Shimcheong
- ·Ministry uncovers 1,802 Youth Protection Act violations
- ·Biden says Hamas must be eliminated, US officials warn war could escalate
- ·S. Korean firms urge US to clarify 'foreign entity of concern'
- ·[Photo News] Mudeungsan fully opens door to public after 57 years
- ·S. Korean firms urge US to clarify 'foreign entity of concern'
- ·Yoon, doctors set to clash over medical school quota
- ·Seoul shares close lower amid woes over Fed's drawn